Summaries for Patients |

Preventing Venous Thromboembolism in Hospitalized Patients: Recommendations From the American College of Physicians FREE

[+] Article, Author, and Disclosure Information

The full reports are titled “Venous Thromboembolism Prophylaxis in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians” and “Venous Thromboembolism Prophylaxis in Hospitalized Medical Patients and Those With Stroke: A Background Review for an American College of Physicians Clinical Practice Guideline.” They are in the 1 November 2011 issue of Annals of Internal Medicine (volume 155, pages 625-632 and pages 602-615). The first report was written by A. Qaseem, R. Chou, L.L. Humphrey, M. Starkey, and P. Shekelle, for the Clinical Guidelines Committee of the American College of Physicians; the second report was written by F.A. Lederle, D. Zylla, R. MacDonald, and T.J. Wilt.

Ann Intern Med. 2011;155(9):I-38. doi:10.7326/0003-4819-155-9-201111010-00002
Text Size: A A A

Who developed these guidelines?

The American College of Physicians (ACP) developed these recommendations. Members of ACP are internists—specialists in the care of adults.

What is the problem and what is known about it so far?

In venous thromboembolism (VTE), blood clots form in veins, often in the legs. Pieces of these leg clots can break off and travel to the lungs, a serious condition called pulmonary embolism. Factors that increase the risk for VTE include immobility (such as long plane rides or being sick in bed), some medications, and some medical conditions (including cancer).

Injections of small doses of the blood thinners unfractionated heparin or low-molecular-weight heparin can prevent VTE. Because many hospitalized patients have VTE risk factors, many hospitals routinely give patients blood thinners to prevent VTE. However, these medications can cause bleeding. Bleeding due to these medications is usually mild, through the gastrointestinal tract or skin wounds. However, it can be severe and occur in a critical organ, such as the brain. Another way to prevent VTE is to put mechanical devices that squeeze the lower part of patients' legs to prevent clots from forming. These devices are uncomfortable, can cause skin breakdown, and might have the unwanted effect of keeping patients in bed.

The ACP wanted to develop recommendations on the best strategies for preventing VTE in hospitalized patients.

How did the ACP develop these recommendations?

The ACP reviewed studies on the benefits and harms of blood thinners and mechanical devices for preventing VTE in patients hospitalized for medical illnesses or stroke and who did not have surgery. The outcomes of interest were patient death up to 120 days after being hospitalized, symptomatic leg vein clots, pulmonary embolism, death from pulmonary embolism, any bleeding, major bleeding, and skin breakdown. The ACP considered the quality and strength of the available information when making these recommendations.

What did the authors find?

Available information shows that using heparin to prevent VTE decreases pulmonary embolism in nonsurgical patients, does not decrease death rates, and leads to more bleeding complications. No differences in benefits or harms were found between the types of heparin used. Mechanical devices provided no benefit and caused side effects.

What does the ACP recommend that patients and doctors do?

Assess the risk for VTE and bleeding in medical patients and patients with stroke before starting VTE prevention.

Do not use blood thinners to prevent VTE in hospitalized nonsurgical patients unless the risk for VTE is greater than the risk for bleeding.

Do not use mechanical devices to prevent VTE in hospitalized nonsurgical patients.

Hospital performance measures should not promote universal VTE prevention regardless of a patient's individual risks for VTE and bleeding.

What are the cautions related to these recommendations?

These recommendations do not apply to patients hospitalized for surgery. Surgical patients have different risk levels for both VTE and bleeding than nonsurgical patients.





Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Submit a Comment/Letter
Submit a Comment/Letter

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.


Want to Subscribe?

Learn more about subscription options

Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.